Oxidation and Nitration of Catecholamines by Nitrogen Oxides Derived from Nitric Oxide

Cyril Daveu, Claudine Servy, Maryvonne Dendane, +2

Nitric Oxide

Chemical EngineeringEngineeringReactive Nitrogen SpecieNitric OxideNitrogen Oxides Derived +4

Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy

Philippe Beauverger, Marie‐Laure Ozoux, Guillaume Bégis, +16

Cardiovascular Research

Precise Engineering of Multifunctional PEGylated Polyester Nanoparticles for Cancer Cell Targeting and Imaging

Nicolas Mackiewicz, Julien Nicolas, Nadège Handké, +6

Chemistry of Materials

Definition of a Pharmacophore for Partial Agonists of Serotonin 5-HT₃ Receptors

Cyril Daveu, Ronan Bureau, Isabelle Baglin, +3

Journal of Chemical Information and Computer Sciences

Hydrogen Bond AcceptorsDrug TargetNeurotransmitterPsychopharmacologyPharmacotherapy +14

Molecular Design Based on 3D-Pharmacophore. Application to 5-HT Subtypes Receptors

Ronan Bureau, Cyril Daveu, Jean‐Charles Lancelot, +1

Journal of Chemical Information and Computer Sciences

Drug TargetMolecular BiologyChemical BiologyPharmaceutical ChemistryMolecular Design +19

Novel antagonists of serotonin-4 receptors: Synthesis and biological evaluation of pyrrolothienopyrazines

Stéphane Lemaître, Alban Lepailleur, Ronan Bureau, +10

Bioorganic & Medicinal Chemistry

Serotonin-4 ReceptorsMedicineMechanism Of ActionPharmacological AgentNovel Antagonists +4

Association of Two 3D QSAR Analyses. Application to the Study of Partial Agonist Serotonin-3 Ligands

Ronan Bureau, Cyril Daveu, Isabelle Baglin, +3

Journal of Chemical Information and Computer Sciences

Qsar AnalysesDrug TargetPsychotropic MedicationMolecular BiologyPharmacotherapy +19

SAR340835, a Novel Selective Na+/Ca2+ Exchanger Inhibitor, Improves Cardiac Function and Restores Sympathovagal Balance in Heart Failure

Michel Pelat, Fabrice Barbe, Cyril Daveu, +20

Journal of Pharmacology and Experimental Therapeutics

First tricyclic oximino derivatives as 5-HT3 ligands

Isabelle Baglin, Cyril Daveu, Jean‐Charles Lancelot, +6

Bioorganic & Medicinal Chemistry Letters

Inorganic ChemistryHeterocyclicChemistry5-Ht3 LigandsInorganic Compound

Molecular Design Based on 3D-Pharmacophore. Application to 5-HT₄ Receptor

Ronan Bureau, Cyril Daveu, Stéphane Lemaître, +4

Journal of Chemical Information and Computer Sciences

Drug TargetChemical BiologyMolecular DesignMolecular PharmacologyMedicinal Chemistry +16